nodes	percent_of_prediction	percent_of_DWPC	metapath
Toremifene—ABCB1—Dactinomycin—testicular cancer	0.108	0.172	CbGbCtD
Toremifene—CYP3A4—Ifosfamide—testicular cancer	0.0763	0.122	CbGbCtD
Toremifene—CYP1A2—Etoposide—testicular cancer	0.0696	0.111	CbGbCtD
Toremifene—ABCB1—Vinblastine—testicular cancer	0.0675	0.108	CbGbCtD
Toremifene—ABCB1—Cisplatin—testicular cancer	0.0619	0.0987	CbGbCtD
Toremifene—ABCB1—Etoposide—testicular cancer	0.0608	0.097	CbGbCtD
Toremifene—ABCB1—Doxorubicin—testicular cancer	0.0415	0.0661	CbGbCtD
Toremifene—CYP3A4—Vinblastine—testicular cancer	0.0405	0.0645	CbGbCtD
Toremifene—ABCB1—Methotrexate—testicular cancer	0.0402	0.0641	CbGbCtD
Toremifene—CYP3A4—Etoposide—testicular cancer	0.0365	0.0581	CbGbCtD
Toremifene—CYP3A4—Doxorubicin—testicular cancer	0.0249	0.0396	CbGbCtD
Toremifene—Leukopenia—Ifosfamide—testicular cancer	0.00106	0.00285	CcSEcCtD
Toremifene—Mediastinal disorder—Cisplatin—testicular cancer	0.00106	0.00284	CcSEcCtD
Toremifene—Oedema—Dactinomycin—testicular cancer	0.00106	0.00284	CcSEcCtD
Toremifene—Asthenia—Chlorambucil—testicular cancer	0.00105	0.00282	CcSEcCtD
Toremifene—Arrhythmia—Cisplatin—testicular cancer	0.00105	0.00282	CcSEcCtD
Toremifene—Abnormal vision—Epirubicin—testicular cancer	0.00105	0.00281	CcSEcCtD
Toremifene—Alopecia—Cisplatin—testicular cancer	0.00104	0.00279	CcSEcCtD
Toremifene—Pruritus—Chlorambucil—testicular cancer	0.00104	0.00278	CcSEcCtD
Toremifene—Thrombocytopenia—Dactinomycin—testicular cancer	0.00104	0.00278	CcSEcCtD
Toremifene—Dry eye—Doxorubicin—testicular cancer	0.00103	0.00276	CcSEcCtD
Toremifene—Malnutrition—Cisplatin—testicular cancer	0.00102	0.00275	CcSEcCtD
Toremifene—Dyspnoea—Bleomycin—testicular cancer	0.00101	0.00271	CcSEcCtD
Toremifene—Chest pain—Ifosfamide—testicular cancer	0.00101	0.00271	CcSEcCtD
Toremifene—Thrombophlebitis—Epirubicin—testicular cancer	0.00101	0.00271	CcSEcCtD
Toremifene—Anorexia—Dactinomycin—testicular cancer	0.00101	0.0027	CcSEcCtD
Toremifene—Eye disorder—Etoposide—testicular cancer	0.00101	0.0027	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Ifosfamide—testicular cancer	0.001	0.00269	CcSEcCtD
Toremifene—Decreased appetite—Bleomycin—testicular cancer	0.000985	0.00264	CcSEcCtD
Toremifene—Angiopathy—Etoposide—testicular cancer	0.000977	0.00262	CcSEcCtD
Toremifene—Mediastinal disorder—Etoposide—testicular cancer	0.000971	0.00261	CcSEcCtD
Toremifene—Abnormal vision—Doxorubicin—testicular cancer	0.00097	0.0026	CcSEcCtD
Toremifene—Pain—Bleomycin—testicular cancer	0.000969	0.0026	CcSEcCtD
Toremifene—Oedema—Ifosfamide—testicular cancer	0.000969	0.0026	CcSEcCtD
Toremifene—Chills—Etoposide—testicular cancer	0.000966	0.00259	CcSEcCtD
Toremifene—Vision blurred—Cisplatin—testicular cancer	0.000964	0.00259	CcSEcCtD
Toremifene—Asthenia—Vinblastine—testicular cancer	0.000963	0.00258	CcSEcCtD
Toremifene—Tremor—Cisplatin—testicular cancer	0.000959	0.00257	CcSEcCtD
Toremifene—Alopecia—Etoposide—testicular cancer	0.000952	0.00255	CcSEcCtD
Toremifene—Lethargy—Methotrexate—testicular cancer	0.000952	0.00255	CcSEcCtD
Toremifene—Nervous system disorder—Ifosfamide—testicular cancer	0.00095	0.00255	CcSEcCtD
Toremifene—Thrombocytopenia—Ifosfamide—testicular cancer	0.000949	0.00255	CcSEcCtD
Toremifene—Skin disorder—Ifosfamide—testicular cancer	0.000941	0.00253	CcSEcCtD
Toremifene—Hyperhidrosis—Ifosfamide—testicular cancer	0.000937	0.00251	CcSEcCtD
Toremifene—Hot flush—Epirubicin—testicular cancer	0.000933	0.0025	CcSEcCtD
Toremifene—Thrombophlebitis—Doxorubicin—testicular cancer	0.000933	0.0025	CcSEcCtD
Toremifene—Vomiting—Chlorambucil—testicular cancer	0.000931	0.0025	CcSEcCtD
Toremifene—Menopausal symptoms—Epirubicin—testicular cancer	0.000925	0.00248	CcSEcCtD
Toremifene—Anorexia—Ifosfamide—testicular cancer	0.000924	0.00248	CcSEcCtD
Toremifene—Decreased appetite—Dactinomycin—testicular cancer	0.000919	0.00247	CcSEcCtD
Toremifene—Leukopenia—Cisplatin—testicular cancer	0.000916	0.00246	CcSEcCtD
Toremifene—Fatigue—Dactinomycin—testicular cancer	0.000912	0.00245	CcSEcCtD
Toremifene—Back pain—Etoposide—testicular cancer	0.000907	0.00243	CcSEcCtD
Toremifene—Pain—Dactinomycin—testicular cancer	0.000904	0.00243	CcSEcCtD
Toremifene—Cardiac failure—Epirubicin—testicular cancer	0.000894	0.0024	CcSEcCtD
Toremifene—Lethargy—Epirubicin—testicular cancer	0.000891	0.00239	CcSEcCtD
Toremifene—Dizziness—Vinblastine—testicular cancer	0.000888	0.00238	CcSEcCtD
Toremifene—Mood swings—Methotrexate—testicular cancer	0.000883	0.00237	CcSEcCtD
Toremifene—Ataxia—Methotrexate—testicular cancer	0.000877	0.00235	CcSEcCtD
Toremifene—Diplopia—Epirubicin—testicular cancer	0.000873	0.00234	CcSEcCtD
Toremifene—Nausea—Chlorambucil—testicular cancer	0.00087	0.00234	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—testicular cancer	0.000865	0.00232	CcSEcCtD
Toremifene—Dyspnoea—Ifosfamide—testicular cancer	0.000864	0.00232	CcSEcCtD
Toremifene—Hot flush—Doxorubicin—testicular cancer	0.000863	0.00232	CcSEcCtD
Toremifene—Liver function test abnormal—Methotrexate—testicular cancer	0.000861	0.00231	CcSEcCtD
Toremifene—Affect lability—Epirubicin—testicular cancer	0.000859	0.00231	CcSEcCtD
Toremifene—Menopausal symptoms—Doxorubicin—testicular cancer	0.000856	0.0023	CcSEcCtD
Toremifene—Vomiting—Vinblastine—testicular cancer	0.000853	0.00229	CcSEcCtD
Toremifene—Breast disorder—Methotrexate—testicular cancer	0.000843	0.00226	CcSEcCtD
Toremifene—Vertigo—Etoposide—testicular cancer	0.000842	0.00226	CcSEcCtD
Toremifene—Decreased appetite—Ifosfamide—testicular cancer	0.000842	0.00226	CcSEcCtD
Toremifene—Headache—Vinblastine—testicular cancer	0.000841	0.00226	CcSEcCtD
Toremifene—Leukopenia—Etoposide—testicular cancer	0.000839	0.00225	CcSEcCtD
Toremifene—Gastrointestinal disorder—Ifosfamide—testicular cancer	0.000836	0.00224	CcSEcCtD
Toremifene—Fatigue—Ifosfamide—testicular cancer	0.000835	0.00224	CcSEcCtD
Toremifene—Oedema—Cisplatin—testicular cancer	0.000835	0.00224	CcSEcCtD
Toremifene—Pain—Ifosfamide—testicular cancer	0.000828	0.00222	CcSEcCtD
Toremifene—Constipation—Ifosfamide—testicular cancer	0.000828	0.00222	CcSEcCtD
Toremifene—Cardiac failure—Doxorubicin—testicular cancer	0.000827	0.00222	CcSEcCtD
Toremifene—Mood swings—Epirubicin—testicular cancer	0.000827	0.00222	CcSEcCtD
Toremifene—Lethargy—Doxorubicin—testicular cancer	0.000824	0.00221	CcSEcCtD
Toremifene—Ataxia—Epirubicin—testicular cancer	0.000821	0.0022	CcSEcCtD
Toremifene—Nervous system disorder—Cisplatin—testicular cancer	0.000819	0.0022	CcSEcCtD
Toremifene—Thrombocytopenia—Cisplatin—testicular cancer	0.000818	0.00219	CcSEcCtD
Toremifene—Asthenia—Bleomycin—testicular cancer	0.000813	0.00218	CcSEcCtD
Toremifene—Skin disorder—Cisplatin—testicular cancer	0.000811	0.00218	CcSEcCtD
Toremifene—Diplopia—Doxorubicin—testicular cancer	0.000807	0.00217	CcSEcCtD
Toremifene—Hyperhidrosis—Cisplatin—testicular cancer	0.000807	0.00217	CcSEcCtD
Toremifene—Liver function test abnormal—Epirubicin—testicular cancer	0.000806	0.00216	CcSEcCtD
Toremifene—Pruritus—Bleomycin—testicular cancer	0.000802	0.00215	CcSEcCtD
Toremifene—Chest pain—Etoposide—testicular cancer	0.000798	0.00214	CcSEcCtD
Toremifene—Nausea—Vinblastine—testicular cancer	0.000797	0.00214	CcSEcCtD
Toremifene—Anorexia—Cisplatin—testicular cancer	0.000796	0.00214	CcSEcCtD
Toremifene—Affect lability—Doxorubicin—testicular cancer	0.000795	0.00213	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Etoposide—testicular cancer	0.000793	0.00213	CcSEcCtD
Toremifene—Breast disorder—Epirubicin—testicular cancer	0.000789	0.00212	CcSEcCtD
Toremifene—Mood swings—Doxorubicin—testicular cancer	0.000765	0.00205	CcSEcCtD
Toremifene—Ataxia—Doxorubicin—testicular cancer	0.000759	0.00204	CcSEcCtD
Toremifene—Asthenia—Dactinomycin—testicular cancer	0.000759	0.00204	CcSEcCtD
Toremifene—Thrombocytopenia—Etoposide—testicular cancer	0.000749	0.00201	CcSEcCtD
Toremifene—Liver function test abnormal—Doxorubicin—testicular cancer	0.000746	0.002	CcSEcCtD
Toremifene—Dyspnoea—Cisplatin—testicular cancer	0.000745	0.002	CcSEcCtD
Toremifene—Skin disorder—Etoposide—testicular cancer	0.000743	0.00199	CcSEcCtD
Toremifene—Hyperhidrosis—Etoposide—testicular cancer	0.00074	0.00199	CcSEcCtD
Toremifene—Angina pectoris—Epirubicin—testicular cancer	0.000735	0.00197	CcSEcCtD
Toremifene—Breast disorder—Doxorubicin—testicular cancer	0.00073	0.00196	CcSEcCtD
Toremifene—Anorexia—Etoposide—testicular cancer	0.000729	0.00196	CcSEcCtD
Toremifene—Decreased appetite—Cisplatin—testicular cancer	0.000726	0.00195	CcSEcCtD
Toremifene—Gastrointestinal disorder—Cisplatin—testicular cancer	0.000721	0.00194	CcSEcCtD
Toremifene—Vomiting—Bleomycin—testicular cancer	0.000721	0.00193	CcSEcCtD
Toremifene—Rash—Bleomycin—testicular cancer	0.000715	0.00192	CcSEcCtD
Toremifene—Pain—Cisplatin—testicular cancer	0.000714	0.00192	CcSEcCtD
Toremifene—Dermatitis—Bleomycin—testicular cancer	0.000714	0.00192	CcSEcCtD
Toremifene—Asthenia—Ifosfamide—testicular cancer	0.000695	0.00187	CcSEcCtD
Toremifene—Sweating—Methotrexate—testicular cancer	0.000689	0.00185	CcSEcCtD
Toremifene—Weight increased—Epirubicin—testicular cancer	0.000686	0.00184	CcSEcCtD
Toremifene—Pruritus—Ifosfamide—testicular cancer	0.000685	0.00184	CcSEcCtD
Toremifene—Dyspnoea—Etoposide—testicular cancer	0.000682	0.00183	CcSEcCtD
Toremifene—Angina pectoris—Doxorubicin—testicular cancer	0.00068	0.00182	CcSEcCtD
Toremifene—Hepatobiliary disease—Methotrexate—testicular cancer	0.00068	0.00182	CcSEcCtD
Toremifene—Nausea—Bleomycin—testicular cancer	0.000673	0.00181	CcSEcCtD
Toremifene—Vomiting—Dactinomycin—testicular cancer	0.000672	0.0018	CcSEcCtD
Toremifene—Rash—Dactinomycin—testicular cancer	0.000667	0.00179	CcSEcCtD
Toremifene—Decreased appetite—Etoposide—testicular cancer	0.000665	0.00179	CcSEcCtD
Toremifene—Gastrointestinal disorder—Etoposide—testicular cancer	0.000661	0.00177	CcSEcCtD
Toremifene—Fatigue—Etoposide—testicular cancer	0.00066	0.00177	CcSEcCtD
Toremifene—Neuropathy peripheral—Epirubicin—testicular cancer	0.000659	0.00177	CcSEcCtD
Toremifene—Jaundice—Epirubicin—testicular cancer	0.000656	0.00176	CcSEcCtD
Toremifene—Constipation—Etoposide—testicular cancer	0.000654	0.00176	CcSEcCtD
Toremifene—Pain—Etoposide—testicular cancer	0.000654	0.00176	CcSEcCtD
Toremifene—Sweating—Epirubicin—testicular cancer	0.000645	0.00173	CcSEcCtD
Toremifene—Dizziness—Ifosfamide—testicular cancer	0.000641	0.00172	CcSEcCtD
Toremifene—Hepatobiliary disease—Epirubicin—testicular cancer	0.000636	0.00171	CcSEcCtD
Toremifene—Weight increased—Doxorubicin—testicular cancer	0.000635	0.0017	CcSEcCtD
Toremifene—Nausea—Dactinomycin—testicular cancer	0.000628	0.00169	CcSEcCtD
Toremifene—Visual impairment—Methotrexate—testicular cancer	0.000622	0.00167	CcSEcCtD
Toremifene—Vomiting—Ifosfamide—testicular cancer	0.000616	0.00165	CcSEcCtD
Toremifene—Rash—Ifosfamide—testicular cancer	0.000611	0.00164	CcSEcCtD
Toremifene—Dermatitis—Ifosfamide—testicular cancer	0.00061	0.00164	CcSEcCtD
Toremifene—Neuropathy peripheral—Doxorubicin—testicular cancer	0.00061	0.00164	CcSEcCtD
Toremifene—Jaundice—Doxorubicin—testicular cancer	0.000607	0.00163	CcSEcCtD
Toremifene—Eye disorder—Methotrexate—testicular cancer	0.000603	0.00162	CcSEcCtD
Toremifene—Asthenia—Cisplatin—testicular cancer	0.000599	0.00161	CcSEcCtD
Toremifene—Sweating—Doxorubicin—testicular cancer	0.000597	0.0016	CcSEcCtD
Toremifene—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000589	0.00158	CcSEcCtD
Toremifene—Angiopathy—Methotrexate—testicular cancer	0.000585	0.00157	CcSEcCtD
Toremifene—Visual impairment—Epirubicin—testicular cancer	0.000582	0.00156	CcSEcCtD
Toremifene—Mediastinal disorder—Methotrexate—testicular cancer	0.000581	0.00156	CcSEcCtD
Toremifene—Chills—Methotrexate—testicular cancer	0.000579	0.00155	CcSEcCtD
Toremifene—Nausea—Ifosfamide—testicular cancer	0.000575	0.00154	CcSEcCtD
Toremifene—Alopecia—Methotrexate—testicular cancer	0.00057	0.00153	CcSEcCtD
Toremifene—Mental disorder—Methotrexate—testicular cancer	0.000565	0.00152	CcSEcCtD
Toremifene—Eye disorder—Epirubicin—testicular cancer	0.000564	0.00151	CcSEcCtD
Toremifene—Malnutrition—Methotrexate—testicular cancer	0.000562	0.00151	CcSEcCtD
Toremifene—Asthenia—Etoposide—testicular cancer	0.000549	0.00147	CcSEcCtD
Toremifene—Angiopathy—Epirubicin—testicular cancer	0.000548	0.00147	CcSEcCtD
Toremifene—Mediastinal disorder—Epirubicin—testicular cancer	0.000544	0.00146	CcSEcCtD
Toremifene—Back pain—Methotrexate—testicular cancer	0.000543	0.00146	CcSEcCtD
Toremifene—Chills—Epirubicin—testicular cancer	0.000542	0.00145	CcSEcCtD
Toremifene—Pruritus—Etoposide—testicular cancer	0.000541	0.00145	CcSEcCtD
Toremifene—Arrhythmia—Epirubicin—testicular cancer	0.000539	0.00145	CcSEcCtD
Toremifene—Visual impairment—Doxorubicin—testicular cancer	0.000538	0.00144	CcSEcCtD
Toremifene—Alopecia—Epirubicin—testicular cancer	0.000533	0.00143	CcSEcCtD
Toremifene—Vomiting—Cisplatin—testicular cancer	0.000531	0.00143	CcSEcCtD
Toremifene—Vision blurred—Methotrexate—testicular cancer	0.000529	0.00142	CcSEcCtD
Toremifene—Mental disorder—Epirubicin—testicular cancer	0.000529	0.00142	CcSEcCtD
Toremifene—Rash—Cisplatin—testicular cancer	0.000527	0.00141	CcSEcCtD
Toremifene—Dermatitis—Cisplatin—testicular cancer	0.000526	0.00141	CcSEcCtD
Toremifene—Malnutrition—Epirubicin—testicular cancer	0.000526	0.00141	CcSEcCtD
Toremifene—Eye disorder—Doxorubicin—testicular cancer	0.000522	0.0014	CcSEcCtD
Toremifene—Back pain—Epirubicin—testicular cancer	0.000508	0.00136	CcSEcCtD
Toremifene—Angiopathy—Doxorubicin—testicular cancer	0.000507	0.00136	CcSEcCtD
Toremifene—Dizziness—Etoposide—testicular cancer	0.000506	0.00136	CcSEcCtD
Toremifene—Vertigo—Methotrexate—testicular cancer	0.000505	0.00135	CcSEcCtD
Toremifene—Mediastinal disorder—Doxorubicin—testicular cancer	0.000503	0.00135	CcSEcCtD
Toremifene—Leukopenia—Methotrexate—testicular cancer	0.000503	0.00135	CcSEcCtD
Toremifene—Chills—Doxorubicin—testicular cancer	0.000501	0.00135	CcSEcCtD
Toremifene—Arrhythmia—Doxorubicin—testicular cancer	0.000499	0.00134	CcSEcCtD
Toremifene—Nausea—Cisplatin—testicular cancer	0.000496	0.00133	CcSEcCtD
Toremifene—Vision blurred—Epirubicin—testicular cancer	0.000495	0.00133	CcSEcCtD
Toremifene—Alopecia—Doxorubicin—testicular cancer	0.000494	0.00132	CcSEcCtD
Toremifene—Mental disorder—Doxorubicin—testicular cancer	0.000489	0.00131	CcSEcCtD
Toremifene—Vomiting—Etoposide—testicular cancer	0.000487	0.00131	CcSEcCtD
Toremifene—Malnutrition—Doxorubicin—testicular cancer	0.000486	0.00131	CcSEcCtD
Toremifene—Rash—Etoposide—testicular cancer	0.000482	0.00129	CcSEcCtD
Toremifene—Dermatitis—Etoposide—testicular cancer	0.000482	0.00129	CcSEcCtD
Toremifene—Headache—Etoposide—testicular cancer	0.000479	0.00129	CcSEcCtD
Toremifene—Chest pain—Methotrexate—testicular cancer	0.000478	0.00128	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000475	0.00127	CcSEcCtD
Toremifene—Vertigo—Epirubicin—testicular cancer	0.000472	0.00127	CcSEcCtD
Toremifene—Leukopenia—Epirubicin—testicular cancer	0.00047	0.00126	CcSEcCtD
Toremifene—Back pain—Doxorubicin—testicular cancer	0.00047	0.00126	CcSEcCtD
Toremifene—Vision blurred—Doxorubicin—testicular cancer	0.000458	0.00123	CcSEcCtD
Toremifene—Nausea—Etoposide—testicular cancer	0.000455	0.00122	CcSEcCtD
Toremifene—Nervous system disorder—Methotrexate—testicular cancer	0.000449	0.00121	CcSEcCtD
Toremifene—Thrombocytopenia—Methotrexate—testicular cancer	0.000449	0.0012	CcSEcCtD
Toremifene—Chest pain—Epirubicin—testicular cancer	0.000447	0.0012	CcSEcCtD
Toremifene—Skin disorder—Methotrexate—testicular cancer	0.000445	0.00119	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000444	0.00119	CcSEcCtD
Toremifene—Hyperhidrosis—Methotrexate—testicular cancer	0.000443	0.00119	CcSEcCtD
Toremifene—Vertigo—Doxorubicin—testicular cancer	0.000437	0.00117	CcSEcCtD
Toremifene—Anorexia—Methotrexate—testicular cancer	0.000437	0.00117	CcSEcCtD
Toremifene—Leukopenia—Doxorubicin—testicular cancer	0.000435	0.00117	CcSEcCtD
Toremifene—Oedema—Epirubicin—testicular cancer	0.000429	0.00115	CcSEcCtD
Toremifene—Nervous system disorder—Epirubicin—testicular cancer	0.000421	0.00113	CcSEcCtD
Toremifene—Thrombocytopenia—Epirubicin—testicular cancer	0.00042	0.00113	CcSEcCtD
Toremifene—Skin disorder—Epirubicin—testicular cancer	0.000417	0.00112	CcSEcCtD
Toremifene—Hyperhidrosis—Epirubicin—testicular cancer	0.000415	0.00111	CcSEcCtD
Toremifene—Insomnia—Methotrexate—testicular cancer	0.000415	0.00111	CcSEcCtD
Toremifene—Chest pain—Doxorubicin—testicular cancer	0.000414	0.00111	CcSEcCtD
Toremifene—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000411	0.0011	CcSEcCtD
Toremifene—Anorexia—Epirubicin—testicular cancer	0.000409	0.0011	CcSEcCtD
Toremifene—Dyspnoea—Methotrexate—testicular cancer	0.000409	0.0011	CcSEcCtD
Toremifene—Decreased appetite—Methotrexate—testicular cancer	0.000398	0.00107	CcSEcCtD
Toremifene—Oedema—Doxorubicin—testicular cancer	0.000397	0.00107	CcSEcCtD
Toremifene—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000396	0.00106	CcSEcCtD
Toremifene—Fatigue—Methotrexate—testicular cancer	0.000395	0.00106	CcSEcCtD
Toremifene—Pain—Methotrexate—testicular cancer	0.000392	0.00105	CcSEcCtD
Toremifene—Nervous system disorder—Doxorubicin—testicular cancer	0.000389	0.00104	CcSEcCtD
Toremifene—Thrombocytopenia—Doxorubicin—testicular cancer	0.000389	0.00104	CcSEcCtD
Toremifene—Insomnia—Epirubicin—testicular cancer	0.000388	0.00104	CcSEcCtD
Toremifene—Skin disorder—Doxorubicin—testicular cancer	0.000385	0.00103	CcSEcCtD
Toremifene—Hyperhidrosis—Doxorubicin—testicular cancer	0.000384	0.00103	CcSEcCtD
Toremifene—Dyspnoea—Epirubicin—testicular cancer	0.000382	0.00103	CcSEcCtD
Toremifene—Anorexia—Doxorubicin—testicular cancer	0.000378	0.00102	CcSEcCtD
Toremifene—Decreased appetite—Epirubicin—testicular cancer	0.000373	0.001	CcSEcCtD
Toremifene—Gastrointestinal disorder—Epirubicin—testicular cancer	0.00037	0.000994	CcSEcCtD
Toremifene—Fatigue—Epirubicin—testicular cancer	0.00037	0.000993	CcSEcCtD
Toremifene—Pain—Epirubicin—testicular cancer	0.000367	0.000984	CcSEcCtD
Toremifene—Constipation—Epirubicin—testicular cancer	0.000367	0.000984	CcSEcCtD
Toremifene—Insomnia—Doxorubicin—testicular cancer	0.000359	0.000963	CcSEcCtD
Toremifene—Dyspnoea—Doxorubicin—testicular cancer	0.000354	0.00095	CcSEcCtD
Toremifene—Decreased appetite—Doxorubicin—testicular cancer	0.000345	0.000926	CcSEcCtD
Toremifene—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000343	0.00092	CcSEcCtD
Toremifene—Fatigue—Doxorubicin—testicular cancer	0.000342	0.000918	CcSEcCtD
Toremifene—Pain—Doxorubicin—testicular cancer	0.000339	0.000911	CcSEcCtD
Toremifene—Constipation—Doxorubicin—testicular cancer	0.000339	0.000911	CcSEcCtD
Toremifene—Asthenia—Methotrexate—testicular cancer	0.000329	0.000883	CcSEcCtD
Toremifene—Pruritus—Methotrexate—testicular cancer	0.000324	0.00087	CcSEcCtD
Toremifene—Asthenia—Epirubicin—testicular cancer	0.000308	0.000826	CcSEcCtD
Toremifene—Pruritus—Epirubicin—testicular cancer	0.000303	0.000814	CcSEcCtD
Toremifene—Dizziness—Methotrexate—testicular cancer	0.000303	0.000813	CcSEcCtD
Toremifene—Vomiting—Methotrexate—testicular cancer	0.000291	0.000782	CcSEcCtD
Toremifene—Rash—Methotrexate—testicular cancer	0.000289	0.000776	CcSEcCtD
Toremifene—Dermatitis—Methotrexate—testicular cancer	0.000289	0.000775	CcSEcCtD
Toremifene—Headache—Methotrexate—testicular cancer	0.000287	0.000771	CcSEcCtD
Toremifene—Asthenia—Doxorubicin—testicular cancer	0.000285	0.000764	CcSEcCtD
Toremifene—Dizziness—Epirubicin—testicular cancer	0.000284	0.000761	CcSEcCtD
Toremifene—Pruritus—Doxorubicin—testicular cancer	0.000281	0.000754	CcSEcCtD
Toremifene—Vomiting—Epirubicin—testicular cancer	0.000273	0.000732	CcSEcCtD
Toremifene—Nausea—Methotrexate—testicular cancer	0.000272	0.000731	CcSEcCtD
Toremifene—Rash—Epirubicin—testicular cancer	0.00027	0.000726	CcSEcCtD
Toremifene—Dermatitis—Epirubicin—testicular cancer	0.00027	0.000725	CcSEcCtD
Toremifene—Headache—Epirubicin—testicular cancer	0.000269	0.000721	CcSEcCtD
Toremifene—Dizziness—Doxorubicin—testicular cancer	0.000262	0.000704	CcSEcCtD
Toremifene—Nausea—Epirubicin—testicular cancer	0.000255	0.000684	CcSEcCtD
Toremifene—Vomiting—Doxorubicin—testicular cancer	0.000252	0.000677	CcSEcCtD
Toremifene—Rash—Doxorubicin—testicular cancer	0.00025	0.000672	CcSEcCtD
Toremifene—Dermatitis—Doxorubicin—testicular cancer	0.00025	0.000671	CcSEcCtD
Toremifene—Headache—Doxorubicin—testicular cancer	0.000249	0.000667	CcSEcCtD
Toremifene—Nausea—Doxorubicin—testicular cancer	0.000236	0.000633	CcSEcCtD
